Entry |
|
Name |
Synaptic vesicle cycle - Homo sapiens (human)
|
Description |
Communication between neurons is mediated by the release of neurotransmitter from synaptic vesicles (SVs). At the nerve terminal, SVs cycle through repetitive episodes of exocytosis and endocytosis. SVs are filled with neurotransmitters by active transport. The loaded SVs are then docked at a specialized region of the presynaptic plasma membrane known as the active zone, where they undergo a priming reaction. Upon arrival of an action potential, Ca2+ enters through voltage-gated channels and neurotransmitter is released by exocytosis, usually in less than a millisecond. After fusion, the vesicle is retrieved by endocytosis and reloaded for another round of exocytosis.
|
Class |
Organismal Systems; Nervous system
|
Pathway map |

|
Disease |
H01031 | Orthostatic intolerance |
H02419 | Glycine encephalopathy with normal serum glycine |
|
Drug |
D00197 | Reserpine (JP17/USP/INN) |
D00228 | Amoxapine (JP17/USP/INN) |
D00394 | Trimipramine (USAN/INN) |
D00484 | Protriptyline hydrochloride (USP) |
D00783 | Botulinum toxin type A (JAN) |
D00809 | Amitriptyline hydrochloride (JP17/USP) |
D00811 | Clomipramine hydrochloride (JP17/USP) |
D00812 | Desipramine hydrochloride (JAN/USP) |
D00814 | Doxepin hydrochloride (USP) |
D00815 | Imipramine hydrochloride (JP17/USP) |
D00816 | Nortriptyline hydrochloride (JP17/USP/INN) |
D00817 | Bupropion hydrochloride (JAN/USP) |
D00818 | Maprotiline hydrochloride (JP17/USP) |
D00821 | Venlafaxine hydrochloride (JAN/USP) |
D01107 | Milnacipran hydrochloride (JAN/USAN) |
D01179 | Duloxetine hydrochloride (JAN/USP) |
D01285 | Lofepramine hydrochloride (JAN/USAN) |
D01296 | Methylphenidate hydrochloride (JAN/USP) |
D01304 | Amezinium metilsulfate (JAN) |
D01546 | Dothiepin hydrochloride (USAN) |
D02074 | Amphetamine sulfate (USP) |
D02078 | Dextroamphetamine sulfate (USP) |
D02080 | Phendimetrazine tartrate (USP) |
D02170 | Indeloxazine hydrochloride (JAN/USAN) |
D02182 | Cocaine hydrochloride (JP17/USP) |
D02237 | Guanethidine sulfate (USAN) |
D02242 | Methamphetamine hydrochloride (JP17/USP) |
D02408 | Trimipramine maleate (JAN/USP) |
D02570 | Desvenlafaxine succinate (USAN) |
D02571 | Sibutramine hydrochloride (USP) |
D02572 | Viloxazine hydrochloride (USAN) |
D02573 | Reboxetine mesylate (USAN) |
D02574 | Atomoxetine hydrochloride (JAN/USP) |
D02704 | Tampramine fumarate (USAN) |
D02735 | Rimabotulinumtoxin B (USAN) |
D03491 | Cidoxepin hydrochloride (USAN) |
D03721 | Dexmethylphenidate hydrochloride (USAN) |
D03740 | Dextroamphetamine (USAN) |
D03801 | Diethylpropion hydrochloride (USP) |
D04382 | Guanethidine monosulfate (USP) |
D04473 | Hydroxyamphetamine hydrobromide (USP) |
D04747 | Lisdexamfetamine dimesylate (USAN) |
D04999 | Methylphenidate (USAN/INN) |
D05119 | Napamezole hydrochloride (USAN) |
D05120 | Napitane mesylate (USAN) |
D05200 | Nomifensine maleate (USAN) |
D05284 | Oxaprotiline hydrochloride (USAN) |
D05454 | Phenmetrazine hydrochloride (USP) |
D05459 | Phentermine hydrochloride (USP) |
D05663 | Pyrovalerone hydrochloride (USAN) |
D05692 | Radafaxine hydrochloride (USAN) |
D05997 | Talopram hydrochloride (USAN) |
D06004 | Tandamine hydrochloride (USAN) |
D07449 | Amitriptylinoxide (INN) |
D07515 | Benzfetamine hydrochloride |
D07806 | Dexmethylphenidate (INN) |
D07938 | Bupropion hydrobromide (USAN) |
D08071 | Imipramine pamoate (USP) |
D08072 | Imipraminoxide hydrochloride |
D08348 | Phendimetrazine hydrochloride |
D08575 | Tetrabenazine (JAN/INN) |
D09340 | Esreboxetine (USAN/INN) |
D09341 | Esreboxetine succinate (USAN) |
D10012 | Incobotulinumtoxin A (JAN/USAN) |
D10072 | Levomilnacipran (USAN/INN) |
D10089 | Amitifadine hydrochloride (USAN) |
D10133 | Levomilnacipran hydrochloride (USAN) |
D10199 | Tapentadol hydrochloride (JAN) |
D10698 | Centanafadine hydrochloride (USAN) |
D10701 | Deutetrabenazine (USAN/INN) |
D10870 | Dasotraline hydrochloride (USAN) |
D10999 | Valbenazine tosylate (USAN) |
D11172 | Midomafetamine (USAN/INN) |
D11328 | Solriamfetol hydrochloride (USAN) |
D11405 | Prabotulinumtoxin A (USAN) |
D11619 | Desvenlafaxine succinate anhydrous |
D11622 | Amphetamine aspartate monohydrate |
D11623 | Dextroamphetamine saccharate |
D11688 | Ampreloxetine (USAN/INN) |
D11689 | Ampreloxetine hydrochloride (USAN) |
D11940 | Toludesvenlafaxine (USAN/INN) |
D11941 | Toludesvenlafaxine hydrochloride (USAN) |
|
Other DBs |
|
Organism |
Homo sapiens (human) [GN: hsa]
|
Gene |
140679 | SLC32A1; solute carrier family 32 member 1 [KO:K15015] |
6570 | SLC18A1; solute carrier family 18 member A1 [KO:K08155] |
6571 | SLC18A2; solute carrier family 18 member A2 [KO:K08155] |
6572 | SLC18A3; solute carrier family 18 member A3 [KO:K14636] |
57084 | SLC17A6; solute carrier family 17 member 6 [KO:K12302] |
246213 | SLC17A8; solute carrier family 17 member 8 [KO:K12302] |
57030 | SLC17A7; solute carrier family 17 member 7 [KO:K12302] |
6844 | VAMP2; vesicle associated membrane protein 2 [KO:K13504] |
5864 | RAB3A; RAB3A, member RAS oncogene family [KO:K07882] |
22999 | RIMS1; regulating synaptic membrane exocytosis 1 [KO:K15291] |
6812 | STXBP1; syntaxin binding protein 1 [KO:K15292] |
6616 | SNAP25; synaptosome associated protein 25 [KO:K18211] |
773 | CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344] |
774 | CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849] |
4905 | NSF; N-ethylmaleimide sensitive factor, vesicle fusing ATPase [KO:K06027] [EC:3.6.4.6] |
8775 | NAPA; NSF attachment protein alpha [KO:K15296] |
8218 | CLTCL1; clathrin heavy chain like 1 [KO:K04646] |
161 | AP2A2; adaptor related protein complex 2 subunit alpha 2 [KO:K11824] |
160 | AP2A1; adaptor related protein complex 2 subunit alpha 1 [KO:K11824] |
163 | AP2B1; adaptor related protein complex 2 subunit beta 1 [KO:K11825] |
1173 | AP2M1; adaptor related protein complex 2 subunit mu 1 [KO:K11826] |
1175 | AP2S1; adaptor related protein complex 2 subunit sigma 1 [KO:K11827] |
525 | ATP6V1B1; ATPase H+ transporting V1 subunit B1 [KO:K02147] |
526 | ATP6V1B2; ATPase H+ transporting V1 subunit B2 [KO:K02147] |
245973 | ATP6V1C2; ATPase H+ transporting V1 subunit C2 [KO:K02148] |
528 | ATP6V1C1; ATPase H+ transporting V1 subunit C1 [KO:K02148] |
51382 | ATP6V1D; ATPase H+ transporting V1 subunit D [KO:K02149] |
90423 | ATP6V1E2; ATPase H+ transporting V1 subunit E2 [KO:K02150] |
529 | ATP6V1E1; ATPase H+ transporting V1 subunit E1 [KO:K02150] |
9296 | ATP6V1F; ATPase H+ transporting V1 subunit F [KO:K02151] |
9550 | ATP6V1G1; ATPase H+ transporting V1 subunit G1 [KO:K02152] |
127124 | ATP6V1G3; ATPase H+ transporting V1 subunit G3 [KO:K02152] |
534 | ATP6V1G2; ATPase H+ transporting V1 subunit G2 [KO:K02152] |
8992 | ATP6V0E1; ATPase H+ transporting V0 subunit e1 [KO:K02153] |
155066 | ATP6V0E2; ATPase H+ transporting V0 subunit e2 [KO:K02153] |
10312 | TCIRG1; T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154] |
23545 | ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154] |
50617 | ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154] |
535 | ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154] |
9114 | ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146] |
245972 | ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146] |
51606 | ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144] |
527 | ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155] |
533 | ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661] |
6529 | SLC6A1; solute carrier family 6 member 1 [KO:K05034] |
6530 | SLC6A2; solute carrier family 6 member 2 [KO:K05035] |
6531 | SLC6A3; solute carrier family 6 member 3 [KO:K05036] |
6532 | SLC6A4; solute carrier family 6 member 4 [KO:K05037] |
9152 | SLC6A5; solute carrier family 6 member 5 [KO:K05038] |
6536 | SLC6A9; solute carrier family 6 member 9 [KO:K05038] |
6534 | SLC6A7; solute carrier family 6 member 7 [KO:K05040] |
6538 | SLC6A11; solute carrier family 6 member 11 [KO:K05044] |
6539 | SLC6A12; solute carrier family 6 member 12 [KO:K05045] |
6540 | SLC6A13; solute carrier family 6 member 13 [KO:K05046] |
6505 | SLC1A1; solute carrier family 1 member 1 [KO:K05612] |
6506 | SLC1A2; solute carrier family 1 member 2 [KO:K05613] |
6507 | SLC1A3; solute carrier family 1 member 3 [KO:K05614] |
6511 | SLC1A6; solute carrier family 1 member 6 [KO:K05617] |
6512 | SLC1A7; solute carrier family 1 member 7 [KO:K05618] |
|
Compound |
|
Reference |
|
Authors |
Li L, Chin LS |
Title |
The molecular machinery of synaptic vesicle exocytosis. |
Journal |
|
Reference |
|
Authors |
Nestler EJ, Hyman SE, Malenka RC. |
Title |
Molecular neuropharmacology: A foundation for clinical neuroscience |
Journal |
The McGraw-Hill Companies, Inc. (2001) |
Reference |
|
Authors |
Chapman ER |
Title |
How does synaptotagmin trigger neurotransmitter release? |
Journal |
|
Reference |
|
Authors |
Benfenati F, Onofri F, Giovedi S |
Title |
Protein-protein interactions and protein modules in the control of neurotransmitter release. |
Journal |
|
Reference |
|
Authors |
de Saint Basile G, Menasche G, Fischer A |
Title |
Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. |
Journal |
|
Reference |
|
Authors |
Carr CM, Munson M |
Title |
Tag team action at the synapse. |
Journal |
|
Reference |
|
Authors |
Sudhof TC |
Title |
The synaptic vesicle cycle. |
Journal |
|
Reference |
|
Authors |
Gundelfinger ED, Kessels MM, Qualmann B |
Title |
Temporal and spatial coordination of exocytosis and endocytosis. |
Journal |
|
Reference |
|
Authors |
Tang J, Maximov A, Shin OH, Dai H, Rizo J, Sudhof TC |
Title |
A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. |
Journal |
|
Reference |
|
Authors |
Chapman ER |
Title |
Synaptotagmin: a Ca(2+) sensor that triggers exocytosis? |
Journal |
|
Reference |
|
Authors |
Sudhof TC |
Title |
The synaptic vesicle cycle: a cascade of protein-protein interactions. |
Journal |
|
Reference |
|
Authors |
Rizo J, Sudhof TC |
Title |
Snares and Munc18 in synaptic vesicle fusion. |
Journal |
|
Reference |
|
Authors |
Malsam J, Kreye S, Sollner TH |
Title |
Membrane fusion: SNAREs and regulation. |
Journal |
|
Related pathway |
|
KO pathway |
|
LinkDB |
|